Continuous glucose monitoring can be successfully initiated during hospitalization with training for hospital staff, robust ...
Most continuous glucose monitoring metrics were not associated with HbA1c for adults with normal glycemic levels, according ...
With significant upside potential, DexCom, Inc. (NASDAQ:DXCM) secures a spot on our list of the 13 Best Quality Stocks to Buy ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them. DexCom ...
Mass General Brigham researchers found that continuous glucose monitoring metrics were reflective of a common measure of glucose (hemoglobin A1c) in patients with diabetes, but fell short for people w ...
The GS3 CGM system. [Image courtesy of SiBionics] SiBionics announced the presentation of new data supporting its continuous glucose monitoring (CGM) and ketone monitoring (CKM) devices. The ...
Now, it’s worth noting Stock Advisor's total average return is 1,079% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...
Shares of DexCom (NASDAQ:DXCM) fell for the third straight session on Friday to reach the lowest level since April, even as ...
VIENNA--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose ...
DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose biosensing technology for ...
The company is presenting several abstracts during the five-day conference showcasing clinical and real-world evidence that support the benefits of its products. Dexcom is presenting several abstracts ...